| Hans-Günter Meyer-Thompson | Buprenorphin
Pharmacokinetic and pharmaceutical properties of a novel buprenorphine/naloxone sublingual tablet for opioid substitution therapy versus conventional buprenorphine/naloxone sublingual tablet in healthy volunteers.
Pharmacokinetic and pharmaceutical properties of a novel buprenorphine/naloxone sublingual tablet for opioid substitution therapy versus conventional buprenorphine/naloxone sublingual tablet in healthy volunteers.
Jönsson M, Mundin G, Sumner M.
Eur J Pharm Sci. 2018 Jun 22;122:125-133. doi: 10.1016/j.ejps.2018.06.024.
Abstract
https://www.sciencedirect.com/science/article/pii/S092809871830280X